Celiac disease is a common genetic autoimmune disorder triggered by gluten, often undiagnosed. Learn symptoms, testing, and ...

Having a second autoimmune disease alongside multiple sclerosis (MS) does not accelerate disability progression, according to ...

NewsdayTV's Amy McGorry lives with autoimmune hepatitis and primary biliary cholangitis, which have damaged her liver ...

According to the Autoimmune Association, approximately 50 million Americans live with an autoimmune disease, yet these ...

After failing to muster sufficient support for an IPO last year, autoimmune and inflammatory disease specialist Odyssey ...

The California-based biotech has hired Omeros and AbbVie alum Nadia Dac as its new chief commercial officer, where she will ...

UCB has struck a deal to acquire Candid Therapeutics for $2 billion upfront, hijacking a planned reverse merger with Rallybio ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...

Erin Moriarty opened up about one of the most physically grueling chapters of her time on The Boys. The actress revealed how ...

To have a drug that has an impact on mortality, it’s of huge interest and a benefit for patients with ILD,’ said rheumatologist Voon Ong, MBBS, PhD, who was not involved in the study.

A second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech ...

The buyout involves a portfolio of antibody drugs Candid licensed from China-based biotechs and that UCB sees as part of the “next wave” of care for immunological conditions.